VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 94 filers reported holding VBI VACCINES INC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $15,339 | -28.7% | 50,625 | -8.0% | 0.00% | – |
| Q4 2022 | $21,528 | -96.5% | 55,044 | -93.7% | 0.00% | – |
| Q3 2022 | $615,000 | +12.2% | 871,479 | +28.6% | 0.00% | – |
| Q2 2022 | $548,000 | -31.2% | 677,832 | +41.3% | 0.00% | – |
| Q1 2022 | $797,000 | -11.4% | 479,765 | +24.8% | 0.00% | – |
| Q4 2021 | $900,000 | -4.9% | 384,357 | +26.4% | 0.00% | – |
| Q3 2021 | $946,000 | +3.6% | 304,132 | +11.8% | 0.00% | – |
| Q2 2021 | $913,000 | -0.1% | 272,135 | -7.4% | 0.00% | – |
| Q1 2021 | $914,000 | +29.8% | 293,805 | +14.8% | 0.00% | – |
| Q4 2020 | $704,000 | +12.1% | 255,999 | +16.7% | 0.00% | – |
| Q3 2020 | $628,000 | +258.9% | 219,426 | +288.9% | 0.00% | – |
| Q2 2020 | $175,000 | – | 56,427 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |